MedPath

VISHAL UPPAL

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

Pre-emptive Opioid Treatment to Prevent Rebound Pain After Arthroscopic Rotator Cuff Repair and/or Acromioplasty Under General Anesthesia and Interscalene Block

Phase 4
Completed
Conditions
Rotator Cuff Injury
Pain
Interventions
First Posted Date
2016-10-19
Last Posted Date
2022-11-08
Lead Sponsor
Vishal Uppal
Target Recruit Count
73
Registration Number
NCT02939209
Locations
🇨🇦

Nova Scotia Health Authority Queen Elizabeth II Hospital Halifax Infirmary site, Halifax, Nova Scotia, Canada

🇨🇦

St Joseph's (McMaster University), Hamilton, Ontario, Canada

A Randomized Controlled Trial Comparing Intrathecal Morphine With Quadratus Lumborum Block for Post-cesarean Delivery Analgesia

Not Applicable
Conditions
Cesarean Section
First Posted Date
2016-08-18
Last Posted Date
2021-01-05
Lead Sponsor
Vishal Uppal
Target Recruit Count
76
Registration Number
NCT02871713
Locations
🇨🇦

IWK Health Centre, Halifax, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.